Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

WAYZATA CHILDREN'S CLINIC P.A.

NPI: 1023081577 · MINNETONKA, MN 55305 · Pediatrics Physician · NPI assigned 02/07/2006

$2.01M
Total Medicaid Paid
79,838
Total Claims
71,594
Beneficiaries
42
Codes Billed
2018-01
First Month
2024-12
Last Month

Provider Details

Authorized OfficialENGELBREKT, MARTHA (PRESIDENT)
NPI Enumeration Date02/07/2006

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 16,995 $160K
2019 18,687 $463K
2020 12,649 $403K
2021 15,963 $532K
2022 8,975 $265K
2023 3,604 $95K
2024 2,965 $96K

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
S0302 Completed early periodic screening diagnosis and treatment (epsdt) service (list in addition to code for appropriate evaluation and management service) 13,632 12,311 $446K
99213 Office or other outpatient visit for the evaluation and management of an established patient, low complexity 9,643 8,327 $422K
99214 Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 4,892 4,290 $316K
X5622 5,493 4,885 $241K
99392 Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) 2,516 2,314 $143K
99391 Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) 1,620 1,402 $87K
99393 Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) 1,393 1,307 $75K
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine 7,224 6,500 $74K
90472 Immunization administration, each additional vaccine (list separately) 3,537 3,181 $46K
99188 6,605 6,080 $32K
99394 Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) 493 456 $32K
G2023 Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source 955 870 $22K
92551 5,285 4,796 $22K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 191 177 $9K
96110 Developmental screening, with scoring and documentation, per standardized instrument 1,430 1,090 $8K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe 196 189 $7K
96127 1,410 1,289 $6K
87430 784 684 $6K
99173 5,358 4,910 $5K
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) 120 118 $4K
0240U 32 31 $4K
87081 567 497 $2K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets 14 14 $1K
99215 Prolong outpt/office vis 16 13 $1K
90686 2,542 2,323 $995.94
90474 142 131 $878.39
90473 69 67 $875.91
T1013 Sign language or oral interpretive services, per 15 minutes 28 26 $484.72
36416 133 96 $319.31
36415 Collection of venous blood by venipuncture 115 106 $285.02
90670 618 562 $232.84
90672 121 111 $137.63
94760 185 159 $121.78
90648 614 559 $23.76
90633 69 66 $20.40
96160 1,424 1,329 $11.31
90723 170 160 $0.00
90680 96 90 $0.00
90651 13 13 $0.00
91300 13 13 $0.00
87400 54 27 $0.00
90734 26 25 $0.00